rituximab
Showing 1 - 6 of 6
Refractory Myasthenia Gravis, Rituximab Trial in Guangzhou (Rituximab)
Recruiting
- Refractory Myasthenia Gravis
- Rituximab
-
Guangzhou, ChinaFirst Affiliated Hospital, Sun Yat-Sen University
Apr 26, 2022
Rituximab in Children With Blood Diseases
Not yet recruiting
- Rituximab
- +2 more
- Rituximab
- Rituximab (once a week)
- (no location specified)
Apr 8, 2022
COVID19 Vaccination, Rituximab, Immunosuppression Trial in Bern (History of exposure to anti-CD20 treatment since 01/01/2010,
Recruiting
- COVID19 Vaccination
- +2 more
- History of exposure to anti-CD20 treatment since 01/01/2010
- Completion of COVID19 vaccine at least 4 weeks ago
-
Bern, BE, SwitzerlandUniversity Hospital Bern Inselspital
May 27, 2021
Diffuse Large B-cell Lymphoma, Rituximab, Toripalimab Trial in Beijing (Toripalimab combine with Rituximab)
Not yet recruiting
- Diffuse Large B-cell Lymphoma
- +2 more
- Toripalimab combine with Rituximab
-
Beijing, ChinaCancer Institute/Hospital, Chinese Academy of Medical Sciences &
Jun 12, 2020
Chidamide, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse Trial in Shanghai (Chidamide combined with R-GDP)
Unknown status
- Chidamide
- +15 more
- Chidamide combined with R-GDP
-
Shanghai, Shanghai, China
- +1 more
Dec 12, 2017